Literature DB >> 22056709

[A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascular coagulation].

Akihiko Takeda1, Fumiaki Kawara, Katsuhiro Onishi, Akihiro Higashida, Satoshi Mamori, Chou Ashida, Toshio Okutani, Hajime Yamada, Takeshi Kondo.   

Abstract

We report an 87-year-old woman who was admitted to our hospital due to anemia and extremely elevated serum alkaline phosphatase (ALP) levels. We diagnosed advanced gastric cancer with disseminated carcinomatosis of the bone marrow and multiple bone metastasis. She was immediately treated with low-dose S-1 (50mg/body, p.o., days 1-14) and zoledronic acid hydrate (4mg/body, i.v., day 1) to avoid disseminated intravascular coagulation (DIC). After 1 course of the treatment, she could completely avoid DIC and we found the primary lesion and the metastasis had decreased. Now she is an outpatient and continues treatment without relapse for about 6 months. We consider low-dose S-1 and zoledronic acid hydrate combination therapy to be an effective strategy against advanced gastric cancer with disseminated carcinomatosis of the bone marrow and multiple bone metastasis in very elderly cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056709

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  2 in total

Review 1.  Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: What has been done for the past, and what will be needed in future?

Authors:  Haruo Iguchi
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

2.  Disseminated carcinomatosis of the bone marrow from pancreatic cancer: a case report.

Authors:  Hiroki Namikawa; Yasuhiko Takemoto; Ayako Makuuchi; Masanori Kobayashi; Shigeki Kinuhata; Mina Morimura; Takashi Ikebe; Hiromu Tanaka; Taichi Shuto
Journal:  BMC Cancer       Date:  2016-10-13       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.